These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24120784)

  • 1. Re: Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
    Richie JP
    J Urol; 2013 Nov; 190(5):1767-8. PubMed ID: 24120784
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
    Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
    Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curing metastatic cancer: lessons from testicular germ-cell tumours.
    Masters JR; Köberle B
    Nat Rev Cancer; 2003 Jul; 3(7):517-25. PubMed ID: 12835671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targets for the treatment of testicular germ cell tumors.
    Chieffi P
    Mini Rev Med Chem; 2007 Jul; 7(7):755-9. PubMed ID: 17627586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antitumour activity of cisplatin and two new cisplatin-analogues JM8 and JM9 in human testicular carcinoma xenografts.
    Harstrick A; Casper J; Schmoll HJ
    Int J Androl; 1987 Feb; 10(1):139-45. PubMed ID: 3034790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model.
    Schobert R; Biersack B; Dietrich A; Effenberger K; Knauer S; Mueller T
    J Med Chem; 2010 Sep; 53(18):6595-602. PubMed ID: 20731355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
    Schlappack OK; Bush C; Delic JI; Steel GG
    Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cisplatin in the treatment of testicular carcinoma].
    van Groeningen CJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1986 Nov; 130(44):1980-4. PubMed ID: 3022163
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors.
    Zschäbitz S; Lasitschka F; Jäger D; Grüllich C
    Ann Oncol; 2016 Jul; 27(7):1356-60. PubMed ID: 27029705
    [No Abstract]   [Full Text] [Related]  

  • 10. Cisplatin-related Cerebral Infarction in Testicular Germ Cell Cancer: Short Report of Three Cases and P in testicular germ cell cancer: Short report of three cases and pathomechanism.
    Lange J; Audebert HJ; Endres M; Rocco A
    Clin Neurol Neurosurg; 2017 Jan; 152():76-77. PubMed ID: 27923208
    [No Abstract]   [Full Text] [Related]  

  • 11. Cisplatin related cardiotoxicity - acute and chronic cardiovascular morbidity in a testicular cancer survivor.
    Morrow AJ; Cameron AC; Payne AR; White J; Lang NN
    Scott Med J; 2020 Feb; 65(1):24-27. PubMed ID: 31886736
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer.
    Fosså SD; Aass N
    Br J Urol; 1989 May; 63(5):531-4. PubMed ID: 2543475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells.
    Gerwing M; Jacobsen C; Dyshlovoy S; Hauschild J; Rohlfing T; Oing C; Venz S; Oldenburg J; Oechsle K; Bokemeyer C; von Amsberg G; Honecker F
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):1979-94. PubMed ID: 27424191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
    Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
    Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic stroke during cisplatin-based chemotherapy for testicular germ cell tumor: case report and review of the literature.
    Meattini I; Scotti V; Pescini F; Livi L; Sulprizio S; Palumbo V; Sarti C; Biti G
    J Chemother; 2010 Apr; 22(2):134-6. PubMed ID: 20435575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary evaluation of cisplatin in the treatment of malignant testicular neoplasms other than seminomas].
    Madej G; Zborzil J; Siedlecki P; Porwit-Ksiazek A
    Pol Tyg Lek; 1981 Jun; 36(26):967-70. PubMed ID: 6270638
    [No Abstract]   [Full Text] [Related]  

  • 17. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
    Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
    Powles T; Shamash J; Berney D; Oliver RT
    Br J Cancer; 2003 Sep; 89(6):1140-1; author reply 1141-2. PubMed ID: 12966438
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity.
    Schaffrath J; Schmoll HJ; Voigt W; Müller LP; Müller-Tidow C; Mueller T
    PLoS One; 2017; 12(6):e0178930. PubMed ID: 28591197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.